The financial terms of the agreement were not disclosed.
“We feel fortunate to be able to initiate this collaboration with a well-recognized institution like CHOP…This is an important step in further advancing and strengthening our [mitochondrial research] program, as well as in the development of novel treatment opportunities for people with mitochondrial medicine disorders,” said Magnus Hansson, CMO of NeuroVive.
More articles on transactions and valuations:
Ponder & Co: 2016 M&A activity down from last year
This week’s 3 most-read transactions and valuations stories
ECRI creates M&A service to help hospitals, health systems during transition
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.